Answers are grounded in this paper and cite their sources.
Methotrexate (MTX) is one of commonly used chemotherapeutic drugs, with well-known nephrotoxic effect. This study aimed to investigate the protective mechanisms of gossypin; a bioflavonoid present in plants, against MTX-induced nephrotoxicity. Rats were allocated into 4 groups: control, gossypin, MTX, and gossypin/MTX groups. Evaluation of renal function and histological images were done. Renal tissue oxidative markers of lipid peroxidation, total nitrite/nitrate (NO) level, reduced glutathione (GSH) and superoxide dismutase (SOD) were measured. Inflammatory and apoptotic markers as matrix metalloproteinase-9 (MMP-9) and beta-cell lymphoma-2 (Bcl-2) mRNA and protein expressions, respectively, as well as renal immunohistochemical expression of cyclooxygenase-II (COX-II) and fas ligand, were assessed. Renal P-glycoprotein (P-gp) expression was also measured. MTX caused a significant elevation in kidney functions, with noticeable elevation in oxidative stressmarkers’levels,aswell asCOX-II and fas ligand expressions. Moreover, MTX decreased renal antioxidant enzymes, P-gp level, and Bcl-2 expression. Gossypin administration significantly improved renal functions and oxidative insults, in addition to significant improvement of inflammatory and apoptotic parameters. Gossypin administration before MTX also ameliorated renal damage, at least in part, via modulation of P-gp level. In conclusion, gossypin may be an effective nephroprotective adjuvant to MTX through antioxidant, anti-apoptotic, and anti-inflammatory mechanisms.
No takes yet. Share an insight, caveat, or question.
Hafez et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: